Pricing Log in Create free account
Saturday 17 October 2026 Export LLY’s income statement to Excel — free account

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,257.03 5.42 +0.43%
Market cap
$1.18T
P/E
42.2×
Fwd P/E
33.1×
Dividend yield
0.53%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Eli Lilly and Company (LLY) Gross margin

Alert me on Gross margin

Eli Lilly and Company's gross margin over the twelve months to 30 June 2026 was 83.4%, up 0.4 percentage points from fiscal 2025 (83.0%). Over the past ten years it has ranged from 73.1% (fiscal 2016) to 83.0% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers General industry median of 72.8% and above the Healthcare sector median of 53.5%.

Gross margin, annual

Embed this chart

Annual newest first

Period Gross margin Change (points)
FY2025 83.0% 1.73
FY2024 81.3% 2.06
FY2023 79.3% 2.48
FY2022 76.8% 2.59
FY2021 74.2% (3.48)
FY2020 77.7% (1.19)
FY2019 78.9% 0.63
FY2018 78.2% 0.49
FY2017 77.7% 4.64
FY2016 73.1% (1.67)

Quarterly newest first

Period Gross margin Change (points)
Jun 2026 85.8% 3.85
Mar 2026 81.9% (0.60)
Dec 2025 82.5% (0.38)
Sep 2025 82.9% (1.36)
42 more quarters

Against its own ten years

Low 73.1% High 83.0%
Ten-year median 77.7%
Current reading's percentile 100

Gross margin against peers

Company Gross margin
LLY Eli Lilly and Company 83.4%
AZN AstraZeneca PLC compare 81.9%
GILD Gilead Sciences, Inc. compare 79.6%
NVS Novartis AG compare 74.7%
PFE Pfizer Inc. compare 73.2%
MRK Merck & Co., Inc. compare 73.0%
ABBV AbbVie Inc. compare 71.5%
AMGN Amgen Inc. compare 69.5%
JNJ Johnson & Johnson compare 67.6%
Drug Manufacturers General industry median 72.8%
Healthcare sector median 53.5%
Market median 46.2%

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on LLY